NATURES SUNSHINE PRODUCTS INC (NATR)

Pharmaceutical Preparations

Latest Price

$13.07

TTM P/E

12.94

Normalized P/E

18.20

Div Yield

Book Value

9.58

P/B Ratio

1.36

Valuation metrics

EPS: $1.06

Book value / share: $9.23

Formula: √(22.5 × EPS × BVPS)

Graham Number

$14.83

+14% upside

Norm. op. income: $20M (median of 7yr)

Tax rate: 31%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$13.17

+1% upside

Base FCF: $28M (median of recent 5yr)

Growth: 5%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$33.27

+155% upside

EPS: $1.06

Target P/E: 18×

Formula: EPS × P/E

P/E Fair Value

$19.08

+46% upside

71.8% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
WYNNEFIELD CAPITAL INC	2.47M	$53.0M	14.04%	--	2026-06-30
BlackRock, Inc.	989.0K	$21.0M	5.61%	-75.4K	2026-06-30
DIMENSIONAL FUND ADVISORS LP	923.6K	$20.0M	5.24%	+28.2K	2026-06-30
AMERICAN CENTURY COMPANIES INC	714.8K	$15.0M	4.06%	+140.0K	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	604.4K	$13.0M	3.43%	+7.6K	2026-06-30
RENAISSANCE TECHNOLOGIES LLC	527.6K	$11.0M	3.00%	-4.4K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	379.9K	$8.0M	2.16%	+7.4K	2026-06-30
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.	340.0K	$7.0M	1.93%	--	2026-06-30
STATE STREET CORP	326.9K	$7.0M	1.86%	+1.1K	2026-06-30
Hillsdale Investment Management Inc.	304.6K	$6.0M	1.73%	-12.3K	2026-06-30